ConductScience.org, home

Paper35720296

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.

Furukawa M and 10 others. Front Immunol, 2022. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience. Papers, record 35720296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35720296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.
PubMed
Journal
Front Immunol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.99
iCite
Revised in PubMed
2022-07-16
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Furukawa MMasashi
2Chan EGErnest G
3Ryan JPJohn P
4Hyzny EJEric J
5Sacha LMLauren M
6Coster JNJenalee N
7Pilewski JMJoseph M
8Lendermon EAElizabeth A
9Kilaru SDSilpa D
10McDyer JFJohn F
11Sanchez PGPablo G

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Epstein-Barr Virus InfectionsMajor topic
Kidney TransplantationMajor topic
Lung TransplantationMajor topic
Aged
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Basiliximab
Herpesvirus 4, Human
Humans
Immunosuppressive Agents
Retrospective Studies

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135133655Risk factors of bronchial dehiscence after primary lung transplantation.J Card Surg2022https://conductscience.org/library/papers/35133655PubMed
231548030
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match.
J Heart Lung Transplant2019https://conductscience.org/library/papers/31548030PubMed
325769073Evaluation of Alemtuzumab Versus Basiliximab Induction: A Retrospective Cohort Study in Lung Transplant Recipients.Transplantation2015https://conductscience.org/library/papers/25769073PubMed
424750290To induce or not to induce: a 21st century evaluation of lung transplant immunosuppression's effect on survival.Clin Transplant2014https://conductscience.org/library/papers/24750290PubMed
525039364Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study.Am J Transplant2014https://conductscience.org/library/papers/25039364PubMed
626833657The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.Am J Transplant2016https://conductscience.org/library/papers/26833657PubMed
730645645Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience.PLoS One2019https://conductscience.org/library/papers/30645645PubMed
831874120Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival.Am J Transplant2020https://conductscience.org/library/papers/31874120PubMed
934738249Outcomes with alemtuzumab induction therapy in lung transplantation: a comprehensive large-scale single-center analysis.Transpl Int2021https://conductscience.org/library/papers/34738249PubMed
1021420318Five-year outcomes with alemtuzumab induction after lung transplantation.J Heart Lung Transplant2011https://conductscience.org/library/papers/21420318PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
41753126Interleukin-2 Receptor Antagonist Induction Therapy in Lung Transplantation-A Meta-Analysis of Reconstructed Time-to-Event Data.J Clin Med2026https://conductscience.org/library/papers/41753126PubMed
41200160Regulatory T cell therapy in lung transplantation: bridging the gap from bench to bedside.Front Immunol2025https://conductscience.org/library/papers/41200160PubMed
40726985Comparative efficacy and safety of induction therapy in solid organ transplantation: a systematic review and network meta-analysis.Front Immunol2025https://conductscience.org/library/papers/40726985PubMed
40429403Inefficiency Rates of Biological Immunosuppressive Induction Agents Used in Organ Transplantation: A Pharmacovigilance Study.J Clin Med2025https://conductscience.org/library/papers/40429403PubMed
39642952Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohort.J Heart Lung Transplant2025https://conductscience.org/library/papers/39642952PubMed
39551266The role of induction therapy in lung transplantation.Am J Transplant2025https://conductscience.org/library/papers/39551266PubMed
39115489Small airway brush gene expression predicts chronic lung allograft dysfunction and mortality.J Heart Lung Transplant2024https://conductscience.org/library/papers/39115489PubMed
38380332Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation.Front Immunol2024https://conductscience.org/library/papers/38380332PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD521043PubTator's text mininghttps://conductscience.org/library/genes/1043NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35720296

GET https://conductscience.org/api/papers/v1/35720296/authors